Skip to main content

Table 1 Characteristics of youth participants

From: A qualitative study exploring how young people perceive and experience substance use services in British Columbia, Canada

Characteristics Participants N = 18a
Socio-demographics N (%) / Median
Ageb
 Age (Median) 21
Gender
 Woman 10 (55.6)
 Man 6 (33.3)
 Non-binary 1 (5.6)
 Not sure/questioning 1 (5.6)
Ethnicityc
 White/Caucasian 12 (66.7)
 Middle Eastern/North African 2 (11.1)
 East Asian 2 (11.1)
 Southeast Asian 2 (11.1)
 South Asian 1 (5.6)
 Chinese 1 (5.6)
 First Nation/Metis/Inuit 1 (5.6)
School or employed
 Both 7 (38.9)
 School 8 (44.4)
 Employed 2 (11.1)
 Neither 1 (5.6)
Highest level of education
 Some high school 6 (33.3)
 High school diploma 2 (11.2)
 Some college or technical school education 1 (5.6)
 Some university 6 (33.3)
 Bachelor’s degree 2 (11.1)
 Master’s degree 1 (5.6)
Living situation
 With my parents(s) or guardian(s) 8 (44.4)
 Apartment 6 (33.3)
 House 1 (5.6)
 Single room occupancy hotel 1 (5.6)
 University dorm 1 (5.6)
 Part time with parents and partner 1 (5.6)
Substance use within lifetime (other than prescribed by a physician)d
 Alcohol 18 (100)
 Marijuana/Cannabis 18 (100)
 Psychedelics/hallucinogens 12 (66.7)
 Amphetamines (MDMA/ecstasy) 9 (50.0)
 Stimulants (e.g., powder cocaine, crack cocaine, crystal meth, Adderall, Dexedrine, Prozac) 9 (50.0)
 Non-prescription or illicit opioids (e.g., fentanyl, heroin, Percocet) 4 (22.2)
 Depressants (e.g., benzodiazepines, GBH, Xanax) 6 (33.3)
 Inhalants 2 (11.1)
Substance use in the past 12-months (other than prescribed by a physician)e
 Alcohol 18 (100)
 Marijuana/Cannabis 17 (94.4)
 Psychedelics/hallucinogens 8 (44.4)
 Amphetamines (MDMA/ecstasy) 5 (27.8)
 Stimulants (e.g., powder cocaine, crack cocaine, crystal meth, Adderall, Dexedrine, Prozac) 5 (27.8)
 Non-prescription or illicit opioids (e.g., fentanyl, heroin, Percocet) 1 (5.6)
 Depressants (e.g., benzodiazepines, GBH) 1 (5.6)
 Inhalants 1 (5.6)
Types of treatment for substance use (past 12-months)c
 Counselling 11 (61.1)
 Cognitive Behavioural Therapy 3 (16.7)
 Dialectical Behaviour Therapy 2 (11.1)
 Psychiatry 4 (22.2)
 Peer support 3 (16.7)
 Case management 1 (5.6)
 Harm reduction services 5 (27.8)
 Housing support 1 (5.6)
 None (I never got treatment for substance use) 5 (27.8)
Type of service environment accessed for substance use (past 12-months)c
 School counsellor 5 (27.8)
 Family doctor’s office 5 (27.8)
 Private office or clinic 5 (27.8)
 Community health centre 3 (16.7)
 Community-based Integrated Youth Services (i.e., Foundry centre) 4 (22.2)
 Emergency Department 2 (11.1)
  1. Definitions: MDMA 3,4-Methylenedioxymethamphetamine, GBH gamma-hydroxybutyrate
  2. aThe demographic survey was voluntary. Response rate was 60% (18/30 completed)
  3. bAge is missing for n = 1
  4. cParticipants could select more than 1 response. Therefore, the number of responses may be greater than the total number of participants who completed the survey
  5. dParticipants were asked “Which of the following substances have you used in your lifetime (other than as prescribed by a physician)?”
  6. eParticipants were asked “Which of the following substances have you used in the past 12-months (other than as prescribed by a physician)?”